Press Releases

Apr 30, 2004 Hemispherx Biopharma Accelerates Release Date on Phase 3 Data for Ampligen in CFS

Apr 20, 2004 HEMISPHERX BIOPHARMA CEO TO PRESENT AT WHITE MOUNTAIN CAPITAL BIOTECHNOLOGY CONFERENCE

Apr 19, 2004 HEMISPHERX BIOPHARMA REPORTS PUBLICATION SHOWING SUPERIOR ACTIVITY OF ALFERON AGAINST SARS

Apr 13, 2004 Hemispherx Biopharma to Present First Phase 3 Data on Ampligen in Chronic Fatigue Syndrome at the 17th International Conference on Antiviral Research

Mar 18, 2004 Hemispherx Biopharma Completes Acquisition for Worldwide Rights to Alferon N

Mar 15, 2004 HEMISPHERX BIOPHARMA REPORTS 2003 YEAR-END RESULTS

Mar 02, 2004 HEMISPHERX BIOPHARMA ANNOUNCES FDA AUTHORIZATION FOR A CLINICAL STUDY WITH NEW BIOLOGICAL ALFERON LDO FOR HIV

Feb 25, 2004 HEMISPHERX BIOPHARMA TO PRESENT AT WALL STREET ANALYST FORUM ON MARCH 1st

Feb 18, 2004 HEMISPHERX BIOPHARMA SIGNS OPTION AGREEMENT FOR AMPLIGEN WITH FUJISAWA PHARMACEUTICAL COMPANY

Jan 30, 2004 HEMISPHERX BIOPHARMA FINISHES PHASE 3 CFS CLINICAL TRIAL

60 61 62 63 64 65 66 67 68 69 70

<< < > >>